Roop Lakkaraju
Analyst · Craig-Hallum. Your line is now open
Thank you, Elizabeth. Total revenue for Q2 was $14.9 million compared to $20.6 million in Q2 2015 and $16.6 million in Q1 2016. Services revenue for the quarter was $13.6 million compared to $19.3 million in Q2 of 2015 and $15.3 million in Q1 2016. Sequentially, services revenue decreased as Comcast was at the lower end of the previously provided guidance range of $8.5 million to $10 million and in line with what we communicated on our Q1 call. Office Depot was lower due to traditional seasonality. The year-over-year decline is primarily due to Comcast customer experience improvement efforts. Software and other revenue was $1.3 million in Q2 2016, flat from Q2 2015 and from Q1 2016. The Q2 2016 revenue mix was 91% services and 9% software compared to 94% and 6% in Q2 2015 and 92% and 8% in Q1 2016. In Q2, Comcast represented 58% of our total revenue and Office Depot represented 17%. During Q2 2016, our services our services and overall gross margins were negatively impacted by continued higher than expected large medical claims as a result of us being self insured. Overall, non-GAAP gross margin for Q2 2016 was 14%, compared to 23% in Q2 2015 and 16% in Q1 2016. In Q2 2016, non-GAAP services gross margin was 7% compared to 18% in Q2 2015 and 10% in Q1 2016. The impact of these large medical claims decreased our overall gross margins by approximately 300 basis points. Excluding the impact of these medical claims, overall gross margins would have been 17% within the guidance range we have provided on our Q1 earnings call. As a reminder, last year we moved to a self-insured model for our medical benefits, the change to a self-insured model resulted in a cost savings in fiscal year 2015. However, in fiscal year 2016, we've seen large medical claims more than double on an annualized basis as compared to fiscal year 2015, even though demographically there has been no change in our employee base. As we look towards 2017, we're evaluating various ideas that would allow us to redesign our medical programs to better help us manage claims, while still providing competitive medical benefits for our employees. Non-GAAP software gross margin was 90% in Q2 of 2016, 90% in Q2 2015 and 91% in Q1 2016. Total non-GAAP operating expenses in Q2 2016 came in $7.1 million, an increase from $6.4 million in Q2 2015 and $6.4 million in Q1 2016. The sequential increase was a result of proxy contest related costs. In Q2 2016 we incurred approximately $1.5 million of proxy contest related cost. On a non-GAAP basis, loss from continuing operations for Q2 was $4.9 million or a loss of $0.09 per share. We do anticipate incurring meaningful federal or state income taxes for the foreseeable future as a result of our net operating loss carry forwards. However, to the extent that we have future taxable income, the company will be subject to alternative minimum taxes in certain tax paying jurisdictions. Turning now to the balance sheets, total cash, cash equivalents and investments were $58 million at June 30, 2016, compared to $61.3 million at March 31, 2016. DSOs for the quarter were 58 days same as the prior quarter. At June 30, 2016, less than 1% of our outstanding receivables were greater than 90 days old, deferred revenue was $2.5 million at June 30, 2016 and $2.4 million at March 31, 2016. Total headcount as of June 30, 2016, was 1,433 consisting of 169 corporate employees and 1,264 work-from-home technicians. This compares to a March 31, 2016, headcount of 1,604 consisting of 198 corporate employees and 1,406 work-from-home technicians. In addition to our work-from-home technicians, we use contract labor in our operations. For the third quarter of 2016, we expect our revenue range to be between $14.6 million to $15.4 million. We expect a revenue mix of 91% services, 9% software. We expect the overall non-GAAP gross margin to be in the range of 13% to 15% as we have assumed that the high level of medical claims expenses will continue into the second half of 2016. We expect our non-GAAP software gross margin to be between 89% to 91% and we expect non-GAAP operating expenses to decrease sequentially by approximately 25% as a result of our cost reduction plan as announced in April 2016 and the absence of any proxy contest cost. Based on the foregoing, our outlook for Q3 non-GAAP results from continuing operations is a loss of $0.05 to a loss of $0.07 per share. As we have previously discussed, our quarterly non-GAAP results are generally indicative of our cash usage or cash generation excluding capital expenditures. During Q3 we expect to incur less than $50,000 of non-recurring cap full expenditures associated with improvements to our IT infrastructure. For the full year 2016, we expect total revenue to be in the range of $60 million to $64 million as a result of our higher medical claims expenses incurred through Q2 and anticipated level of medical expenses through the remainder of 2016, we expect non-GAAP results from continuing operations to be between a loss of $0.23 to a loss of $0.27 per share. We estimate that higher medical claims for fiscal year 2016 will negatively impact our results by approximately $0.04 per share. Exiting 2016 we expect overall gross margins to be in low 20s as a result of our continued operational execution and focused cost management even with the assumed higher medical expenses. We still expect to finish with an ending cash balance between $52 million to $54 million. With that, we’d like to open the call to questions.